Vinblastine Sulfate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00570 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rhabdomyosarcoma (disease) | KG + DL |
| 2 | botryoid-type embryonal rhabdomyosarcoma of the vagina | KG + DL |
| 3 | parameningeal embryonal rhabdomyosarcoma | KG + DL |
| 4 | embryonal extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 5 | prostate embryonal rhabdomyosarcoma | KG + DL |
| 6 | extrahepatic bile duct rhabdomyosarcoma | KG + DL |
| 7 | liver sarcoma | KG + DL |
| 8 | monocytic leukemia | KG + DL |
| 9 | neuroblastoma | KG + DL |
| 10 | ganglioneuroblastoma (disease) | KG + DL |
| 11 | retroperitoneal neoplasm | KG + DL |
| 12 | Ewing sarcoma | KG + DL |
| 13 | skeletal muscle neoplasm | KG + DL |
| 14 | vertebral anomalies and variable endocrine and T-cell dysfunction | KG + DL |
| 15 | uterine corpus sarcoma | KG + DL |
| 16 | relapsing-remitting multiple sclerosis | KG + DL |
| 17 | T-cell childhood lymphoblastic lymphoma | KG + DL |
| 18 | T-cell leukemia | KG + DL |
| 19 | gastric mantle cell lymphoma | KG + DL |
| 20 | lymph node cancer | KG + DL |
| 21 | dermatofibrosarcoma protuberans | KG + DL |
| 22 | lissencephaly spectrum disorders | KG + DL |
| 23 | pancytopenia | KG + DL |
| 24 | refractory precursor T-lymphoblastic lymphoma/leukemia | KG + DL |
| 25 | actinic cheilitis | KG + DL |
| 26 | T-lymphoblastic lymphoma | KG + DL |
| 27 | liposarcoma | KG + DL |
| 28 | ovarian lymphoma | KG + DL |
| 29 | composite lymphoma | KG + DL |
| 30 | nasal cavity lymphoma | KG + DL |
| 31 | progressive transformation of germinal centers | KG + DL |
| 32 | AIDS-related primary central nervous system lymphoma | KG + DL |
| 33 | lung lymphoma | KG + DL |
| 34 | adenosarcoma | KG + DL |
| 35 | ovarian myxoid liposarcoma | KG + DL |
| 36 | bladder exstrophy-epispadias-cloacal exstrophy complex | KG + DL |
| 37 | head and neck cancer | KG + DL |
| 38 | orbit sarcoma | KG + DL |
| 39 | synovial chondromatosis | KG + DL |
| 40 | angular cheilitis | KG + DL |
| 41 | upper aerodigestive tract neoplasm | KG + DL |
| 42 | pulmonary blastoma | KG + DL |
| 43 | well-differentiated fetal adenocarcinoma of the lung | KG + DL |
| 44 | primary pulmonary lymphoma | KG + DL |
| 45 | reticulum cell sarcoma | KG + DL |
| 46 | ureteral lymphoma | KG + DL |
| 47 | leukemia (disease) | KG + DL |
| 48 | breast lymphoma | KG + DL |
| 49 | giant cell tumor of soft tissue | KG + DL |
| 50 | bladder exstrophy (disease) | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.